| Prophylaxis Following Occupational Exposure to HIV: Related Resources |
 |
| Content reviewed April 2006 |
 |
 |
|  | | Updates | |  |
| Related Knowledge Base Chapters | |  |
| Journal Articles |  |  | Antiretroviral Post-Exposure Prophylaxis (PEP) for Occupational HIV Exposure Young T, Arens F, Kennedy G, Laurie J, Rutherford G. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002835. Includes commentary from the UCSF Institute for Global Health. |  |  |  | Antiretroviral drug resistance among patients with human immunodeficiency virus who act as sources or potential sources in occupational accidents involving healthcare workers El-Far F, Medeiros EA, Gasparoto CT, Diaz RS. Infect Control Hosp Epidemiol. 2005 Sep;26(9):782-8. |  |  |  | Tolerance of a short course of nevirapine, associated with 2 nucleoside analogues, in postexposure prophylaxis of HIV Rey D, Partisani M, Hess-Kempf G, Krantz V, Priester M, Cheneau C, Bernard-Henry C, de Mautort E, Decroix L, Lang JM. J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1454-6. |  |  |  | Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of healthcare workers. Puro V, Francisci D, Sighinolfi L, Civljak R, Belfiori B, Deparis P, Roda R, Modestino R, Ghinelli F, Ippolito G. J Hosp Infect. 2004 Jun;57(2):179-82. |  |  |  | Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry Wang SA, Panlilio AL, Doi PA, White AD, Stek M Jr, Saah A. Infect Control Hosp Epidemiol. 2000 Dec;21(12):780-5. |  |  |  | Cost effectiveness of human immunodeficiency virus postexposure prophylaxis for healthcare workers Scheid DC, Hamm RM, Stevens KW. Pharmacoeconomics. 2000 Oct;18(4):355-68. |  |
|  |
| Guidelines and Best Practices | |  |
| Online Books and Chapters | |  |
| Clinician Support Tools | |  |
| Slide Sets | |  |
| Links | |  |
|